Crossmark

Efficacy and safety of combination immunotherapy for treating advanced non-clear cell renal cell carcinoma: A multicenter retrospective study in Japan

Crossref DOI link: https://doi.org/10.1038/s41598-025-19523-4

Published Online: 2025-10-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iinuma, Koji

Sano, Yuta

Nishikawa, Kohei

Taniguchi, Tomoki

Matsuyama, Aika

Ozawa, Kaori

Ishida, Takashi

Tochigi, Kosuke

Tamura, Masataka

Kubota, Yasuaki

Akamatsu, Shusuke

Inoue, Takahiro

Koie, Takuya
License Information

Text and Data Mining valid from 2025-10-10

Version of Record valid from 2025-10-10
More Information

Article History

Received: 21 June 2025

Accepted: 9 September 2025

First Online: 10 October 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below